Mereo Stock Alpha and Beta Analysis

MREO
 Stock
  

USD 0.82  0.01  1.20%   

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Mereo BioPharma Group. It also helps investors analyze the systematic and unsystematic risks associated with investing in Mereo BioPharma over a specified time horizon. Remember, high Mereo BioPharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Additionally, see Mereo BioPharma Backtesting, Mereo BioPharma Valuation, Mereo BioPharma Correlation, Mereo BioPharma Hype Analysis, Mereo BioPharma Volatility, Mereo BioPharma History and analyze Mereo BioPharma Performance.
  
Please note that although Mereo BioPharma alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Mereo BioPharma did 0.42  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Mereo BioPharma Group stock's relative risk over its benchmark. Mereo BioPharma Group has a beta of 1.23  . Let's try to break down what Mereo's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mereo BioPharma will likely underperform.
.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Mereo BioPharma Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Mereo BioPharma market risk premium is the additional return an investor will receive from holding Mereo BioPharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Mereo BioPharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Mereo BioPharma's performance over market.
α-0.42   β1.23
90 days against NYA

Mereo BioPharma expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Mereo BioPharma's Buy-and-hold return. Our buy-and-hold chart shows how Mereo BioPharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Mereo BioPharma Market Price Analysis

Market price analysis indicators help investors to evaluate how Mereo BioPharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mereo BioPharma shares will generate the highest return on investment. By understating and applying Mereo BioPharma stock market price indicators, traders can identify Mereo BioPharma position entry and exit signals to maximize returns.

Mereo BioPharma Return and Market Media

The median price of Mereo BioPharma for the period between Thu, Sep 8, 2022 and Wed, Dec 7, 2022 is 0.94 with a coefficient of variation of 11.79. The daily time series for the period is distributed with a sample standard deviation of 0.11, arithmetic mean of 0.91, and mean deviation of 0.1. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Other09/12/2022
2
Short Interest in Mereo BioPharma Group plc Expands By 11.3 ...09/19/2022
3
FDA nixes EUA ambitions for Eigers COVID treatment, proposes...10/05/2022
4
Mereo BioPharma Announces Updated Operating Plan to Maximize...10/18/2022
5
Mereo BioPharma Reaches Cooperation Agreement with Rubric Ca...10/28/2022
6
Is Mereo BioPharma Group Using Debt Sensibly - Simply Wall S...11/25/2022
7
EPS Estimate12/05/2022

About Mereo BioPharma Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Mereo or other stocks. Alpha measures the amount that position in Mereo BioPharma Group has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Mereo BioPharma Upcoming Company Events

As portrayed in its financial statements, the presentation of Mereo BioPharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mereo BioPharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Mereo BioPharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Mereo BioPharma. Please utilize our Beneish M Score to check the likelihood of Mereo BioPharma's management manipulating its earnings.
Upcoming Quarterly Report30th of March 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End30th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Build Portfolio with Mereo BioPharma

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Mereo BioPharma Backtesting, Mereo BioPharma Valuation, Mereo BioPharma Correlation, Mereo BioPharma Hype Analysis, Mereo BioPharma Volatility, Mereo BioPharma History and analyze Mereo BioPharma Performance. Note that the Mereo BioPharma Group information on this page should be used as a complementary analysis to other Mereo BioPharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Mereo Stock analysis

When running Mereo BioPharma Group price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Mereo BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Mereo BioPharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Mereo BioPharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...